Do BBH and GNOM hold the same stocks?

By their latest filings, 27% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, BBH or GNOM?

BBH has 64% of its weight in S&P 500 names and GNOM has 21%, so BBH differs more from the index.

Which is cheaper, BBH or GNOM?

BBH charges 0.35% a year and GNOM charges 0.50%, so BBH is cheaper. Fees come from each fund's prospectus.

Data as of Nov 4, 2026.

Thematic ETFs

BBH vs GNOM: Holdings Overlap & Returns

Share on X Download as PDF

Over the year to Nov 4, 2026, BBH returned +47.2% to GNOM's +66.6%; 27% of their weight is in the same names.

askIQ about this page

askIQ about BBH and GNOM

Net assets: $525m on Nov 3, 2026 for VanEck Biotech ETF, and $104m on Oct 12, 2026 for Global X Genomics & Biotechnology ETF.

BBH on its own →GNOM on its own →

At a glance

64.4%

BBH in the S&P 500

21.0%

GNOM in the S&P 500

+47.2%

BBH total return, 1 year

+66.6%

GNOM total return, 1 year

BBH · 1 year to Nov 4, 2026 36% of its weight is outside the S&P 500

64% of BBH's weight is in S&P 500 companies and 36% is outside the index. Holdings as of Nov 2, 2026.

GNOM · 1 year to Nov 4, 2026 79% of its weight is outside the S&P 500

21% of GNOM's weight is in S&P 500 companies and 79% is outside the index. Holdings as of Aug 31, 2026.

Pair scorecard

BBH costs 0.15 points a year less; their one-year returns differ by 19.4 points; BBH is 4.6 times larger.

BBH vs GNOM: Holdings Overlap & Returns
Measure	BBH	GNOM
Return
Measure	BBH	GNOM
Total return, 1 year	+47.2%	+66.6%
Drawdown
Measure	BBH	GNOM
Below its all-time high		36.2%, high on Feb 8, 2021
Benchmark
Measure	BBH	GNOM
What it tracks	Biotech	Genomics and gene editing
Cost and size
Measure	BBH	GNOM
Expense ratio	0.35%	0.50%
Net assets, as of Oct 12, 2026	$482m	$104m
Holdings
Measure	BBH	GNOM
Holdings in common	27%

Method

Risk and return

Apr 18, 2019 to Oct 30, 2026 · 393 weekly returns

BBH GNOM

Return

Total return edge BBH +121.3% +25.4%

Annualized edge BBH +11.1% +3.0%

Price return edge BBH +114.6% +23.4%

Risk

Volatility edge BBH 22.2% 32.9%

Max drawdown edge BBH −37.7% −73.5%

Risk-adjusted

Sharpe edge BBH 0.46 0.17

Sortino edge BBH 0.68 0.25

Calmar edge BBH 0.29 0.04

Reading

From Apr 2019 to Oct 2026, BBH returned more: +121.3% to +25.4%. BBH swung less: 22.2% to 32.9%. BBH fell less at its worst: −37.7% to −73.5%.

Full scorecard

9 measures, with how each is measured Open ↓

Risk and return: BBH vs GNOM: Holdings Overlap & Returns
Measure	BBH	GNOM	Edge	How it is measured
Return
Total return	+121.3%	+25.4%	BBH	Price change plus distributions, reinvested.
Annualized	+11.1%	+3.0%	BBH	Total return as a yearly rate.
Price return	+114.6%	+23.4%	BBH	Price change alone, distributions left out.
Risk
Volatility	22.2%	32.9%	BBH	Spread of weekly returns, annualized. Lower is steadier.
Downside deviation	14.8%	22.3%	BBH	Like volatility, counting only weeks below the Treasury bill rate.
Max drawdown	−37.7%	−73.5%	BBH	Deepest fall from a high to the low after it.
Risk-adjusted
Sharpe	0.46	0.17	BBH	Return above Treasury bills per unit of volatility.
Sortino	0.68	0.25	BBH	Return above Treasury bills per unit of downside deviation.
Calmar	0.29	0.04	BBH	Annualized return divided by the max drawdown.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 393 weekly returns. Cash rate: the 13-week Treasury bill.

What they share

27%

By the books each fund has filed, BBH and GNOM hold 27% of their money in the same securities at the same weight. Holdings dated Aug 31, 2026 and Nov 3, 2026.

50%

0 half 100%

half

27% in common

Positions both hold · largest shared weight first BBH GNOM

Moderna Inc 6.88% 7.50%

Natera Inc 4.44% 4.61%

Vertex Pharmaceuticals Inc 7.98% 3.70%

Illumina Inc 3.37% 4.87%

Guardant Health Inc 2.83% 5.28%

Gilead Sciences Inc 14.17% 1.64%

Biontech Se 1.34% 2.78%

Bio-Techne Corp 1.12% 3.67%

Qiagen Nv 1.02% 3.22%

Biomarin Pharmaceutical Inc 1.00% 3.58%

Only in one fund ↓

Only in BBH

Amgen Inc 16.53%

Regeneron Pharmaceuticals Inc 7.99%

Iqvia Holdings Inc 4.18%

Argenx Se 4.13%

Revolution Medicines Inc 3.82%

Biogen Inc 2.88%

Beone Medicines Ltd 2.56%

United Therapeutics Corp 2.38%

Only in GNOM

Twist Bioscience Corporation 6.34%

10x Genomics, Inc. 5.48%

Genscript Biotech Corp 3.81%

ARROWHEAD PHARMACEUTICALS, INC. 3.31%

Praxis Precision Medicines, Inc. 3.09%

CRISPR Therapeutics AG 3.00%

Veracyte, Inc. 2.61%

CARIS LIFE SCIENCES, INC. 2.38%

Check overlap with more funds →

Window by window

Window by window: BBH vs GNOM: Holdings Overlap & Returns
	Total return
Window	BBH	GNOM
3 months	+24.3%	+24.5%
6 months	+38.3%	+49.4%
1 year	+47.2%	+66.6%
3 years	+75.4%	+81.6%
Since launchNot the same days: BBH Dec 2011 · GNOM Apr 2019	+680.5%	+16.0%

Open this comparison in the app →

Side by side

BBH VanEck Biotech ETF · Holds 25 stocks in biotech, 64% of its weight in S&P 500 companies GNOM Global X Genomics & Biotechnology ETF · Holds 50 stocks in genomics and gene editing, 21% of its weight in S&P 500 companies

Issuer VanEck Global X

Theme Biotech Genomics and gene editing

In the S&P 500 64.4% 21.0%

Active share vs the S&P 500 99.0% 97.6%

In the Nasdaq-100 49.1% 5.3%

Holdings 25 50

Top ten, share of the fund 73.5% 48.8%

Expense ratio 0.35% 0.50%

Fee for the differing part 0.35% 0.51%

Total return, 1 year +47.2% +66.6%

vs its benchmark not measured not measured

Below its high 0.0% −36.2%

Net assets, BBH as of Nov 3, 2026 and GNOM as of Oct 12, 2026 $525m $104m

As of Nov 4, 2026. Source: ETFIQ.

27% of the two portfolios are the same securities at the same weight.

Client brief:

The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.

Your saved page · Privacy.

Alert

About each fund

BBH

By weight, 64% of BBH's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 74% of the fund across 25 positions, as published by its issuer for Nov 3, 2026. Over the year to Nov 4, 2026 the fund returned +47.2% with distributions reinvested.

GNOM

By weight, 21% of GNOM's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 49% of the fund across 50 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +66.6% with distributions reinvested. It sits 36.2% below its all-time high of Feb 8, 2021.

Questions people ask

Do BBH and GNOM hold the same stocks?: By their latest filings, 27% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, BBH or GNOM?: BBH has 64% of its weight in S&P 500 names and GNOM has 21%, so BBH differs more from the index.
Which is cheaper, BBH or GNOM?: BBH charges 0.35% a year and GNOM charges 0.50%, so BBH is cheaper. Fees come from each fund's prospectus.

Other comparisons

BBH vs GNMX BBH vs IDNA BBH vs ARKG BBH vs BBP GNOM vs PBPH GNOM vs FBT GNOM vs XBI GNOM vs IBB

Where to next

All thematic ETFs ranked by the S&P 500 Difference Score →How the scores are computed →BBH on its own →GNOM on its own →BBH dividend history →BBH holdings →GNOM dividend history →GNOM holdings →Method →Standards and sources →

Sources and dates

BBH filings on SEC EDGAR ↗

BBH prospectus with the expense ratio (SEC) ↗

VanEck website ↗

GNOM filings on SEC EDGAR ↗

GNOM prospectus with the expense ratio (SEC) ↗

Global X page for GNOM ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Every number is an ETFIQ calculation with distributions reinvested.

Cite this pageCitation, APA and Markdown

ETFIQ, BBH against GNOM, data as of Nov 4, 2026. https://etfiq.com/compare/themes/bbh-vs-gnom

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.